MPO and Parkinson disease: Experimental evidence shows that NOX4 upregulation leads to mitochondrial dysfunction, initiating a cascade involving neuroinflammatory mediators such as osteopontin (OPN) and myeloperoxidase (MPO), which further promote astrocyte ferroptosis and accelerate PD progression (Boonpraman et al., 2023).